|
The Journal of Internal Korean Medicine 2013;34(4): 466-477. |
동시 간전이 직장 구불결장암 환자의 재발성 복수에 대한 SB 복강 주입의 복수 감소 효과 증례 |
전형준, 김종민, 조종관, 이연월, 한균인, 유화승 |
대전대학교 둔산한방병원 동서암센터 |
Ascites-decreasing Effect of SB Intraperitoneal Injection to a Refractory Ascites Patient
with Synchronous Colorectal Liver Metastasis and Metachronous Peritoneal
Carcinomatosis : A Case Report |
Hyung-joon Jeon, Jong-min Kim, Chong-kwan Cho, Yeon-weol Lee, Kyun-in Han, Hwa-seung Yoo |
East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University |
Correspondence |
Hwa-seung Yoo ,Tel: 042-470-9132, Fax: 042-470-9006, Email: altyhs@dju.kr
|
|
Published online: December 30, 2013. |
|
|
ABSTRACT |
Objectives: To report and demonstrate the effect of decreasing ascites volume by SB intraperitoneal injection to a refractory ascites patient with synchronous colorectal liver metastasis and metachronous peritoneal carcinomatosis.
Methods : Two cycles of intraperitoneal and intravenous SB injection were conducted. Each injection cycle was made up of 4 days. Nine vials of SB were injected to the patient every day. To compare the volume of ascites between pret- and post-treatment, follow-up computed tomography was done on June 3, 2013. To observe other therapeutic effects of SB injection, laboratory tests were conducted periodically.
Results: On the follow-up computed tomography images, the amount of ascites and pleural effusion had decreased compared to the April 30, 2013 computed tomography images. The levels of aspartate transaminase, alanine aminotransferase and lactate dehydrogenase decreased significantly from May 9, to May 30, 2013. The amount of oral intake increased constantly during hospitalization. The patient's symptoms such as abdominal distension, abdominal pain and dyspnea were improving until discharge.
Conclusions: Even if thiese results cannot be applied to every synchronous colorectal cancer liver metastasis patient, we demonstrated that SB intraperitoneal injection has ascites-decreasing effect to refractory ascites patients with synchronous colorectal liver metastasis and metachronous peritoneal carcinomatosis. |
Key words:
SB injection, intraperitoneal, refractory ascites, liver metastasis, peritoneal carcinomatosis |
|
|
|